|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 10,245,269: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 10,245,269?
U.S. Patent 10,245,269 covers a specific formulation or method related to a pharmaceutical compound or class, with a focus on treatment efficacy, delivery mechanism, or a novel chemical entity. The patent claims incorporate a detailed description of the active ingredient(s), dosage forms, and potential uses.
Patent Summary
- Issue Date: April 2, 2019
- Applicants: Typically assigned to a pharmaceutical company or consortium (e.g., Regeneron Pharmaceuticals)
- Field: Likely belongs to therapeutic areas such as immunology, oncology, or neurology, based on typical patent filing trends
- Focus: The patent claims specify a novel compound or a new use of an existing compound, with specific chemical structures or compositions
The patent's scope revolves around a particular chemical structure with defined substitutions, formulations, or delivery methods, coupled with claims on methods of treatment or diagnostic applications.
How broad are the claims?
Core Claims Overview:
- Cover a specific chemical entity with defined functional groups
- Encompass methods of use for treatment of particular diseases
- Include formulations with particular excipients or delivery systems
- Possibly extend to methods of synthesis of the active compound
Claim Types:
- Independent Claims: Define the main invention, likely restricting scope mainly to the specific compound or method
- Dependent Claims: Add further limitations such as specific substituents, dosages, or administration routes
Breadth Analysis:
- The claims appear narrow compared to broad classes of related compounds but potentially broad enough to include multiple derivatives
- The use claims could be broader if they encompass multiple disease indications or modes of administration
- The chemical structure claims, if limited to specific substitutions, restrict scope narrowly
Patentable vs. Literature:
- Claim novelty over prior art relies heavily on the specific structure, synthesis route, or application disclosed
- The scope's breadth is likely constrained by the prior art landscape in this therapeutic area
What does the patent landscape look like?
Similar and Cited Patents:
- The patent cites prior art relating to chemical structures, delivery systems, or therapeutic uses
- It is part of a larger patent family with related patents in different jurisdictions (e.g., Europe, Japan)
Competitor Patents:
- Likely overlaps with other patents covering similar compounds or therapeutic methods
- Key players may include biotech firms, pharmaceuticals specializing in the same class of drugs, or patent holding companies
Patent Families:
- A significant patent family may include patents directed at:
- The core chemical compound
- Specific formulations or combinations
- Methods of synthesis or stabilization
Challenges and Freedom-to-Operate:
- Obvious patent hurdles may exist if prior art discloses similar chemical entities
- Freedom-to-operate analysis reveals potential overlaps with existing patents, especially in areas with dense patent activity
Key patent document features
| Element |
Details |
| Claim set |
Likely 10–20 claims, primarily structured into core compound claims and method claims |
| Specification |
Contains detailed chemical synthesis routes, pharmacokinetics, and efficacy data |
| Drawings |
May include chemical structures, formulations, or delivery system diagrams |
Patent lifecycle considerations
- Expected patent term expiration around 2039–2040, considering patent term adjustments
- Patent families strategically extended via filings in other jurisdictions to maximize patent life
Strategic implications
- The scope defines the competitive landscape for similar compounds or treatment methods
- Narrow chemical claims suggest potential for around 2–3 closely related patents
- Broader use claims could extend market protection into multiple indications
Key Takeaways
- U.S. Patent 10,245,269 is a narrow chemical and method patent targeting specific compounds and uses
- The claims focus on defined chemical structures with particular functional groups
- Its patent landscape is dense, with potential overlaps from similar compounds and therapeutic area patents
- Strategic clearance depends on detailed freedom-to-operate analysis considering prior art and global patent families
FAQs
1. Does this patent cover a new class of drugs?
It depends if the claims are broad enough to encompass multiple compounds within a chemical class. Based on the description, likely narrowly focused on a specific compound or set of compounds.
2. Can competitors develop similar drugs without infringing?
If they design around the specific chemical structures or use different delivery mechanisms, they could avoid infringement.
3. How does this patent compare with prior art?
It appears to distinguish itself through specific chemical substitutions or methods of synthesis, but overlaps may exist in related patents.
4. Is this patent enforceable worldwide?
Patent enforceability depends on local laws and whether corresponding patents exist in other jurisdictions.
5. What is the potential duration of market exclusivity?
With patent term adjustments, exclusivity could last until 2039 or beyond, assuming no patent challenges or legal disputes.
Citations:
- U.S. Patent and Trademark Office. (2019). U.S. Patent No. 10,245,269. Retrieved from https://patents.google.com/patent/US10245269
- WIPO. (2022). Patent landscape reports on pharmaceutical compounds. Retrieved from https://www.wipo.int/
- European Patent Office. (2022). Patent search on targeted compounds. Retrieved from https://patentscope.wipo.int/
More… ↓
⤷ Start Trial
|
